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The temporal regulation of an early gene of the baculovirus Autographa californica nuclear polyhedrosis
virus was examined. We constructed a plasmid (plasmid 39CAT) in which the bacterial gene for chloram-
phenicol acetyltransferase was placed under the control of the promoter for the gene for a A. californica nuclear
polyhedrosis virus 39,000-dalton protein (39K). A transient expression assay of plasmid 39CAT revealed that
the 39K gene was expressed in infected cells but not in uninfected cels, indicating that the 39K gene should be
classified as a delayed-early gene. The 39K promoter also efficiently directed the synthesis of chloramphenicol
acetyltransferase when the plasmid was cotransfected with viral DNA which had been restricted with several
restriction enzymes. To map the location of the gene(s) required for the synthesis of 39K, plasmid 39CAT was
cotransfected with purified restriction fragments of A. californica nuclear polyhedrosis virus DNA. Fragments
which mapped between 90.7 and 100.8 map units induced plasmid 39CAT. Plasmid pEcoRI-B, containing
EcoRI fragment B (90 to 100 map units), activated plasmid 39CAT. Functional mapping of plasmid pEcoRI-B
indicated that the essential region was located between 95.0 and 97.5 map units. The 5' end of this gene was
mapped, and the chloramphenicol acetyltransferase gene was inserted under the control of its promoter.
Transient assay experiments indicated that the trans-acting regulatory gene was expressed in uninfected cells
and is therefore an immediate-early gene. This gene was named IE-1.
The genome of Autographa californica nuclear poly-
hedrosis virus (AcNPV) is a double-stranded, supercoiled,
circular DNA molecule of approximately 128 kilobase pairs.
The temporal regulation of AcNPV gene expression is sim-
ilar to that of most large DNA viruses. The expression of
immediate-early (ca) genes does not require prior viral pro-
tein synthesis, while delayed-early (,B) genes apparently
require an a gene product for expression (25). Synthesis of
late (y) genes is concomitant with, but may not be dependent
upon,, the onset of viral DNA synthesis (12, 25). Bac-
uloviruses are unique in having a fourth temporal class of
genes, the very late (6) genes, which are associated with viral
occlusion. The 8 genes are highly expressed after the release
of extracellular virus, while the synthesis of a, ,B, and fy gene
products is repressed (9, 31, 47). Some genes are expressed
in more than one temporal phase. For example, the gene for
a protein having a molecular weight of 39,000 (39K) is the
most abundantly expressed early gene and is also expressed
late in infection (37, 41). Synthesis of 39K can be detected by
3 to 6 h postinfection, but it has not been determined
whether the 39K gene is an a gene or a 13 gene.
AcNPV early transcripts map to a few dispersed regions of
the genome, while late in infection most of the genome is
transcribed (13, 14, 35). Overlapping nests of transcripts
with coterminal 3' or 5' ends have been mapped in several
regions of the genome (15, 27). One transcription unit was
composed of five early and late RNAs with a common 3'
end. The smallest RNAs appeared early and were replaced
in time by successively larger transcripts, suggesting that
temporal regulation involves sequential activation of up-
stream promoters along with coordinate deactivation of
downstream promoters (15). In contrast, the very late (b)
* Corresponding author.
transcription units are composed of overlapping RNAs with
coterminal 5' ends. Splicing has not been detected in
baculovirus transcripts (26).
Nothing is known about the mechanisms of regulation of
temporal expression in baculoviruses. Two temperature-
sensitive mutants blocked at an early stage of replication
have been described previously (16, 33). The mutations were
mapped to two different regions of the genome, but the
identity and normal function of the mutated genes are
unknown.
We identified and functionally mapped a gene which
regulates temporal expression in AcNPV. The bacterial gene
for chloramphenicol acetyltransferase (CAT) was cloned
under the control of the 39K gene. The resulting construc-
tion, plasmid 39CAT, was active in infected cells but not in
uninfected cells, indicating that the 39K gene is a delayed-
early gene. By using cotransfection of plasmid 39CAT and
purified restriction fragments of viral DNA or cloned vital
DNA fragments, we identified a viral immediate-early gene
which trans-activates 39K gene expression.
MATERIALS AND METHODS
Cells and virus. Spodoptera frugiperda IPL-21 AEIII cells
obtained from S. Weiss (Cetus Corp., Emeryville, Calif.)
were used in transfection experiments. These cells were
propagated in IPL-41 monolayer medium (46) containing 10%
fetal bovine serum (KC Biologicals, Lenexa, Kans.). For
preparation of viral DNA and infected cell RNA, S.
frugiperda clone 9 spinner cultures were grown in TNMFH
medium (20) supplemented with 10% fetal calf serum. The
cells were concentrated by centrifugation at 1,000 x g for 5
min, suspended at a density of 107 cells per ml, and inoculated
with extracellular virus at a multiplicity of 20 PFU per cell.
After a 1-h adsorption period at room temperature, the cells
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were centrifuged as described above and suspended in fresh
TNMFH medium at a density of 106 cells per ml. After 48 h,
the cells were centrifuged at 1,000 x g. The supernatant was
adjusted to 10% polyethylene glycol and 0.1 M NaCl, and the
preparation was gently stirred at 4°C for 1 h. The virus
precipitate was collected by centrifugation at 10,000 x g for
10 min. The pellet was gently suspended in 5 ml of 10 mM Tris
(pH 7.5)-i mM EDTA and then mixed with an equal volume
of 20% polyethylene glycol to 0.2 M NaCl. After 1 h at 4°C,
the precipitated virus was centrifuged and suspended as
described above. The virus suspension was adjusted to 1%
sodium dodecyl sulfate and extracted with phenol.
RNA isolation. Cells were infected as described above. At
6 or 18 h postinfection the cells were centrifuged, washed
once in phosphate-buffered saline, and suspended in five
times the packed cell volume of 6 M guanidinium isothio-
cyanate-5 mM sodium citrate-0.1 M P-mercaptoetha-
nol-0.5% Sarkosyl. Then 1 g of CsCl per ml of supernatant
was added, the mixture was layered onto 1.2 ml of 5.7 M
CsCl, and the preparation was centrifuged at 30,000 rpm in a
type SW60 rotor for 16 h. The RNA pellet was suspended
and extracted as described previously (30).
Recombinant plasmids. The 39CAT plasmids were con-
structed in several steps. First, the termination and
polyadenylation sequences for the polyhedrin gene were
excised from plasmid pAc373 (G. E. Smith, G. Ju, B. L.
Erickson, J. Moschera, H.-W. Lahm, R. Chizzonite, and
M. D. Summers, Proc. Natl. Acad. Sci. USA, in press) with
BamHI and EcoRI. The resulting 3-kilobase (kb) fragment
was cloned into the BamHI and EcoRI sites of pUC8. The
coding sequences for the bacterial CAT gene were derived
from plasmid pCAT (28). The CAT gene was excised with
BamHI and cloned into the BamHI site adjacent to the
polyhedrin sequences. The proper orientation of the CAT
gene was determined by EcoRI digestion. This plasmid had
only one unique cloning site upstream from the CAT gene. A
second unique site was created by removing the SalI site in
the polyhedrin sequences by successively performing the
following steps: partial Sall digestion, purification of full-
length DNA, Klenow repair, blunt end ligation, and trans-
formation of Escherichia coli strain JM83 cells. Plasmid
pAc3075, which had a single SalI site in the multiple cloning
region, was selected. The 5' end of the 39K message has
been mapped to a site ca. 220 base pairs (bp) upstream from
a PvuII site in PstI fragment K of the AcNPV genome (J.
Vlak, no. 23, Abstr. Soc. Invertebr. Pathol. 1985). To
remove the coding sequences between the promoter atd the
PvuII site, plasmid pPstI-K (20 ,ug) was digested with PvuII
and incubated with 0.5 U of Bal 31 buffer at 30°C (30). At
5-min intervals, 10-p.l portions were removed and adjusted to
50 mM EGTA [ethylene glycol-bis(,-aminoethyl ether)-
N,N,N',N'-tetraacetic acid], and the digested ends were
made blunt by incubation with the Klenow fragment of DNA
polymerase I.
The digested DNAs were extracted with phenol, precipi-
tated with ethanol, suspended, and digested with PstI. After
electrophoresis in 1% agarose, fragments ca. 750 to 1,050 bp
long were eluted and cloned into the PstI and SalI (repaired)
sites of pAc3075. Seven plasmids containing different-length
promoter sequences were tested by transfecting AcNPV-
infected S. frugiperda cells and assaying for CAT activity.
The plasmid yielding the highest activity (plasmid 39CAT-4)
was chosen for further study.
The HindIII and EcoRI plasmids were constructed by
cloning the appropriate restriction fragments in the HindIII
and EcoRI sites of PUC8. Recombinant plasmids were
propagated in E. coli strains JM83 and TB1. Plasmid DNA
was isolated by the method of Holmes and Quigley (21) and
purified by centrifugation in cesium chloride-ethidium bro-
mide gradients.
Transfections and CAT assays. Cells were transfected by a
modification of the procedure of Graham and van der Eb
(18). Subconfluent monolayers of S. frugiperda IPL-21
AEIII cells were harvested by scraping with a rubber police-
man and suspended by gentle pipetting. The cells were
seeded at a density of 106 cells per 60-mm dish. The cells
were allowed to attach for 1 h, and then the medium was
replaced with 0.5 ml of fresh medium. DNAs to be
transfected were diluted in 0.5 ml of HEPES (N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered
saline (25 mM HEPES, pH 7.1, 140 mM NaCl) containing
125 mM CaCI2. The unprecipitated DNAs were added
dropwise to the cell monolayers. Calcium phosphate precip-
itates formed due to the CaCl2 in the HEPES-buffered saline
and the phosphate in the medium. Each tratisfection mixture
contained 2 ,ug of 39CAT-4 and 2 ,g of viral or plasmid DNA
unless otherwise noted. For transfections of purified gel
fragments, 10 ,ug of viral DNA was digested with a restric-
tion enzyme, and fragments were separated by electropho-
resis through 0.6% low-melting-temperature agarose. The
purified fragments were eluted by heating the preparation at
650C for 15 min, followed by phenol extraction and ethanol
precipitation. The amount of a DNA fragment purified from
10 jig of digested DNA was added to each dish. For
transfections in which the total amount of transfected DNA
was less than 4 ,g, calf thymus DNA was added to bring the
amount up to 4 ,ug.
Cells were harvested 24 h after transfection, and CAT
assays were performed as described previously (18), except
that cells were broken by three cycles of freezing and
thawing instead of sonication and each assay mixture con-
tained only 0.2 ,uCi of [14C]chloramphenicol.
DNA sequencing. The 39CAT plasmids were digested with
PstI and BamHI, and the promoter fragments were cloned
into the PstI and BamHI sites of M13mp9 (32). Single-
stranded recombinant phage was purified and sequenced by
the dideoxy chain termination method (36). The sequence of
the opposite strand was determined by cloning and sequenc-
ing the appropriate HpaII restriction fragments of PstI-K in
the AccI site of mp9.
Si nuclease mapping of AcNPV DNA. The 5' ends of the
39K and IE-1 transcripts were mapped by the S1 procedure
of Berk and Sharp (6), as modified by Weaver and Weissman
(45); 5'-end-labeled probes were generated by digesting
pPstI-K and pIE-1 with ClaIl and Hinfl, respectively. The 5'
ends were dephosphorylated with calf intestinal phosphatase
(Boehringer Mannheim Biochemicals, Indianapolis, Ind.)
and radiolabeled with T4 polynucleotide kinase (Bethesda
Research Laboratories, Inc., Gaithersburg, Md.) and [y-
32P]ATP (4,000 Ci/mmol). The DNAs were then digested
with PstI (pPstI-K) or BamHI (IE-1), and the appropriate
restriction fragments were purified by agarose gel electro-
phoresis. DNA probes (0.1 ,ug) were hybridized to 10 ,ug of
total cellular RNA in a solution containing 80% formamide,
40 mM PIPES [piperazine-N,N'-bis(2-ethansulfonic acid)]
(pH 6.4), 0.4 M NaCl, and 1 mM EDTA for 4 h at 42°C.
Samples were diluted 10-fold into Si buffer (30 mM sodium
acetate, pH 4.6, 4.5 mM ZnSo4, 0.25 M NaCI, 20,ug of
single-stranded DNA per ml) containing 100 U of Si nucle-
ase per ml and incubated at 37°C for 30 min. Digestion
was terminated by adding 75 ,ul of S1 stop buffer (2.5 M
ammonium acetate, 0.1 M EDTA). The Si hybrids were
J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
FUNCTIONAL MAPPING OF A trans-ACTIVATING GENE
M P C 6h 18h
* -1080
}
-653
B
HHrUUrILJlUHI U IdHLH1THHtHUU UI UULUH,UHrI U
TTGGACATCGTGTCGTTTGAGCGTRTRRRRGRRTRTRTR
AGAGCTARTTTAGGCCRTTTCRCAGTRRTCACCORCARR
6CTGTTCAAGCCTRAGGTGCCTGTCTTCATCRCRRRCGRA
TVTGCCAGGTTGTTGGGCRTTAARAAATATRTCATCRRGR
4
RTACRRACGGGTTGTTTCRARGGTTTRCRRGRAGCRRRCA
9
ATGAGTA ARC GTG CCG GRG CAR CAR TCT CCG
GRG ACT GCG GCC GTG TOC RAR ART GRA ARG
CTG TTG ART AAR CTG GAR
ARC ARA TCC ARC RTG GRC
TCG RCC TCT TRC
CAG
A
C
C - 260
- 244
-240
_i _ - 237
.*e*
CM
control 901 3904 3906 3908 3909 3916 3920
FIG. 1. Si nuclease mapping of the 5' ends of the 39K gene (A), the nucleotide sequence of the 5' end of the gene (B), and transient
expression of chimeric 39CAT plasmids (C). (A) Mapping of the 5' ends of viral transcripts isolated 6 and 18 h postinfection or from control,
uninfected cells (lane C). Total cellular RNA (10 ,ug) was hybridized with 0.1 Fig of the 1.07-kb PstI-ClaII fragment (the position of the label
in the ClaII site is indicated by an asterisk in panel B). The size of the Si-resistant fragment was determined by electrophoresis on a 7 M
urea-5% polyacrylamide gel. An autoradiograph of the gel is shown. The sizes of the molecular weight markers (+X174 HaeIII fragments)
are indicated on the left, and the sizes of the Si-resistant DNAs are indicated on the right. Lane P contained the 5'-end-labeled DNA probe
before digestion. Lane M contained the molecular weight markers. (B) Sequence of the 5' end of the 39K gene. The numbered arrowheads
indicate the extents of the Bal 31 deletions for the plasmids indicated. The arrows marked with E and L indicate the early and late
transcriptional start sites, respectively. The position of the 5' end label used for S1 mapping is indicated by an asterisk. (C) Transient
expression of 39CAT plasmids. S. frugiperda cells were infected with AcNPV 1 h prior to transfection with 2-,ug portions of the plasmids
indicated at the bottom. At 24 h posttransfection, cell extracts were prepared and analyzed for CAT activity. An autoradiograph of the
thin-layer chromatogram is shown. The positions of input unacetylated chloramphenicol (CM) and acetylated products (Ac-CM) are indicated.
precipitated with ethanol, denatured, and analyzed by elec-
trophoresis on 5% polyacrylamide-7 M urea-89 mM Tris
hydrochloride (pH 8.3)-89 mM boric acid-2 mM EDTA gels.
Size standards were derived from 3'-end-labeled HaeIII
digests of XX174 DNA (30).
RESULTS
Temporal regulation of 39K. The 39K gene has been
mapped to EcoRI fragment J of AcNPV DNA (14, 41) (see
Fig. 3 for the location of the 39K gene). The 5' end is located
approximately 220 bp upstream from a PvuII site in AcNPV
DNA PstI fragment K (Vlak, no. 23, Abstr. Soc. Invertebr.
Pathol. 1985). Because baculovirus genes apparently are not
spliced (26), we used high-resolution S1 mapping to deter-
mine the precise location of the 5' end of the 39K gene. The
1,080-bp PstI-ClaII fragment of PstI-K was labeled at the
ClaII site and hybridized to total cellular RNA isolated at 6
and 18 h postinfection (Fig. 1A). The following four S1-
resistant DNA fragments were resolved when the DNA
probe was hybridized to 6-h RNA: a major band at 237
nucleotides, two minor bands at 240 and 244 nucleotides,
and a very faint band at 653 nucleotides. When the probe
was hybridized to 18-h RNA, the same four S1-resistant
bands were observed. In addition, another major band at 260
bp was present.
In order to clone the CAT gene under the control of the
39K promoter, Bal 31 was used to remove the coding
sequences located between the promoter and the PvuII site.
The approximate extent of the Bal 31 deletions was deter-
mined by restriction digestion and agarose gel electrophore-
sis. Six plasmids with promoter fragments of different
lengths were sequenced to determine the precise point at
which the CAT gene was inserted (Fig. 1B). Plasmid
pAc3901 contained the complete 1,080-bp PstI-PvuII frag-
ment. Assuming that the first AUG sequence downstream
from the transcriptional start sites was the initiating AUG
sequence, pAc3901 would be expected to code for an in-
phase fusion protein. In three of the deletions, the CAT gene
A
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FIG. 2. XhoI restriction digest ofAcNPV DNA (A) and transient expression assay of cell extracts cotransfected with 39CAT-4 and purified
fragments (B). AcNPV DNA (10 ,ug) was digested with Xhol, and restriction fragments were separated electrophoretically on 0.6% agarose
gels. Purified fragments were eluted and tested for the ability to induce 39CAT expression. Each transfection mixture contained the total
amount of fragment purified from 10 ,ug of viral DNA.
was inserted into the 39K coding region. Two plasmids,
pAc3908 and pAc3920, were expected to code for out-of-
phase fusion proteins. Plasmid pAc3916 was expected to
code for an in-phase fusion protein. In plasmids pAc3904 and
pAc3909, the CAT gene was inserted 50 or 90 bp down-
stream from the major early transcription start site. In
pAc3906, the early transcription start sites were deleted, and
the CAT gene was inserted 4 bp downstream from the major
late start site. Because there were no AUG codons located
between the early and late start sites, both transcripts were
expected to code for the same protein.
To examine the temporal regulation of the 39K promoter,
S. frugiperda cells were infected with AcNPV and 1 h later
were transfected with 2-pxg portions of the various 39CAT
plasmids. After 24 h, cellular extracts were prepared, and
CAT assays were performed (Fig. 1C). As expected, there
was no CAT activity detected in the two plasmids in which
the CAT gene was inserted out of phase. The in-phase fusion
protein produced by pAc3916 was active. These results
indicate that the assignment of the initiating AUG codon was
correct. Plasmid pAc3901, which encoded a larger fusion
protein, had little activity. The two plasmids in which the
CAT gene was inserted in the 5' leader of the early tran-
scripts were active in directing the synthesis of CAT. The
late promoter also efficiently directed the synthesis of CAT,
as evidenced by the activity observed in cells cotransfected
with pAc3906.
The seven plasmids which we constructed were also used
to transfect S. frugiperda cells that had not been infected
prior to transfection. No CAT activity was observed with
any of the plasmids in extracts of uninfected cells (data not
shown), indicating that the 39K promoter was not transcrip-
tionally active in uninfected cells. These results are consist-
ent with a classification of delayed early for the 39K gene,
because a viral function is apparently required for expres-
sion of the 39K gene. Plasmid pAc3904 (= plasmid 39CAT-4)
was chosen for further study.
Functional mapping of the gene required for 39K expres-
sion. The 39K promoter was efficiently induced when
uninfected cells were cotransfected with 2 ,ug of 39CAT-4
and 2 ,ug of viral DNA. The promoter was also stimulated by
viral DNA that was digested with several different restriction
enzymes prior to transfection (data not shown). To map the
location of the gene(s) required for expression of the 39K
gene, AcNPV DNA was restricted with either KpnI, SstI,
SstII, XhoI, or BamHI. It was necessary to use several
restriction enzymes because many restriction fragments
comigrated on agarose gels. For example, the restriction
digest pattern for XhoI is shown in Fig. 2A. Fragments A and
B, C and D, F and G, and H and I comigrated and so were
tested as pairs. The results of the CAT assays after cotrans-
fection of gel-purified XhoI restriction fragments and
39CAT-4 are shown in Fig. 2B. Cells cotransfected with
39CAT-4 and XhoI fragments C and D synthesized CAT,
indicating that the gene(s) needed to activate the 39K gene
are located on either one or both of these fragments. The
other fragments which induced CAT activity were KpnI
fragments A, B, and C, SacII fragments C and D, SacI
fragments A and B, and BamHI fragment B (data not
shown). By constructing a consensus map from several
digests, it was possible to eliminate all but one fragment from
each digest (Fig. 3). Our combined data indicated that the
region from 90.7 to 0.8 map units (m.u.) contained the gene
required for expression of the 39K gene. The consensus
region was defined by the left end of XhoI fragment C and
the right end of SstII fragment D. The circular AcNPV
genome is presented as linear by convention, with the 0
position of the map at the left end of EcoRI fragment I (40).
EcoRI fragment B (90 to 100 m.u.) covered most of the
consensus region indicated in Fig. 3. This fragment was
cloned into the EcoRI site of pUC8 and tested in the
transient assay system for its ability to induce 39CAT
expression. CAT was efficiently expressed in cells
transfected with 39CAT-4 and pEcoRI-B (data not shown).
To further define the location of the gene required for
expression of the 39K gene, a detailed restriction map of
pEcoRI-B was generated (Fig. 4A). A series of deletions in
EcoRI fragment B was constructed by digestion and religa-
tion with Sall, ClaI, EcoRV, XbaI, or BglII (Fig. 4B). In
addition, plasmids containing HindIII fragments G and F
were cloned and tested. All of the activity was located in
HindlIl fragment G. Deletion of the XbaI fragment between
96.7 and 97.5 m.u. did not eliminate CAT activity, indicating
that the gene was located to the left of 96.7 m.u. on the
physical map. Deletion of the region between the SalI site in
the multiple cloning site and the Sall site at 92.2 m.u. had no
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FIG. 3. Consensus map of the DNA fragments which activate 39CAT-4. Fragments which were positive in the transient expression assay
are indicated by heavy lines. The consensus region is shown as a shaded line. The circular AcNPV genome was linearized at EcoRI fragment
I by convention. The genomic location of the 39K gene is indicated.
effect, indicating that the gene was located to the right of
92.2 m.u.
Two of the deletions (the ClaI and EcoRV deletions) did
not activate 39CAT expression. The ClaI fragment (95 to
99.8 m.u.) and the EcoRV fragment (95.3 to 97.8 m.u.) were
cloned into the AccI or HinclI sites of pUC8 and tested for
their ability to activate 39CAT-4 in the transient assay
system. The plasmid containing the ClaI fragment induced
CAT, but the plasmid containing the EcoRV fragment did
not (data not shown). This result indicated that one end of
the gene required for expression of the 39K gene was located
between the leftmost ClaI and EcoRV sites and the other end
was located to the left of the XbaI site at 97.5 m.u. Because
most AcNPV genes are transcribed from left to right (15, 27)
on the linear map (clockwise on the circular map), we
expected that the end located between the ClaI and EcoRV
sites was the 5' end.
A HyIII
EcORI KhoISol I Sell
I I I
90.0 90.7 912
90.6
922
Plasmid pEcoRI-B was cotransfected with pAc3916,
pAc3909, and pAc3906 to determine whether these CAT
plasmids were activated by the same gene as 39CAT-4 (data
not shown). CAT was expressed in cells transfected with
pAc3916, the plasmid producing an in-phase fusion protein,
and in cells transfected with pAc3909, in which the CAT
gene was inserted in the leader downstream from 39CAT-4.
No CAT activity was detected in cells transfected with
pAc3906, in which the 5' end of the early transcript was
deleted, indicating that the early and late transcripts were
differentially regulated.
Temporal regulation of IE-1. The ClaI fragment of EcoRI-
B was cloned into the AccI site ofpUC8 in both orientations.
In one orientation, digestion with HindIII followed by religa-
tion removed the sequences to the right of 96.9 m.u. The
resulting plasmid, which contained 3 kb of viral DNA, was
designated pIE-1 (for immediate-early gene 1). To confirm
HelEIIIIII 11
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FIG. 4. Detailed restriction map of EcoRI-B (A) and construction of EcoRI fragment B subclones (B). Five subclones were constructed
by restriction with Sall, ClaI, EcoRV, XbaI, and BglII, followed by religation. The regions of EcoRI fragment B deleted by digestion are
indicated by diagonal lines. pHindIII-G and pHindIII-F contained the restriction fragments indicated. The results of a transient expression
assay for each clone are shown by a plus sign (induced 39CAT) or a minus sign (no CAT activity).
m0 T VU
m
L T- I
567VOL. 57, 1986
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
568 GUARINO AND SUMMERS
A
M P CSh
B
1353- _
1078-~
872- * _
_ -850
603- I
_ -341
0
31094
281-
271-
Hincil/Taql 1 2
FIG. 5. S1 mapping of the 5' end of the IE-1 gene (A), construction of an IE-1-CAT plasmid (B), and expression of the plasmid in infected
and uninfected cells (c). (A) Si nuclease mapping of the 5' end of the IE-1 gene. Total cell RNAs (10 ,ug) from cells infected for 6 h or control,
uninfected (c) cells were hybridized with 100-pg portions of an 850-bp BamHI-Hinfl probe (lane P), which was specifically radiolabeled at the
Hinfl site. Sl-resistant hybrids were denatured and analyzed on 7 M urea-5% polyacrylamide gels. The sizes of the XX174 molecular weight
standards (lane M) are indicated on the left, and the sizes of the Si-resistant fragments are indicated on the right. (B) Plasmid IE-1 was
digested with HincII, and a 770-bp TaqI fragment of pCAT which was made blunt ended by Klenow repair treatment was cloned into the
HinclI site. The location and direction of transcription of the IE-1 transcript are indicated by an arrow. The location of the probe for S1
mapping is indicated by an asterisk. (C) AcNPV-infected cells (lane 2) and uninfected cells (lane 1) were transfected with 2 ,ug of IE-1-CAT.
After 24 h, the CAT activity in cellular extracts was assayed. CM, Input unacetylated chloramphenicol; Ac-Cm, acetylated chloramphenicol
products.
tht the temporal regulation of this gene was characteristic of
an immediate-early gene, a chimeric IE-1-CAT plasmid was
constructed. The 5' end of the IE-1 gene was located by Si
mapping, using an 850-bp BamHI-Hinfl probe exclusively
labeled at the Hinfl site. Figure SB shows the map location
of the probe. The 5' end of the IE-1 gene was located 341 bp
upstream from the Hinfl site. A HincII site was mapped
approximately 20 bp downstream from the transcription start
site. The CAT gene was cloned into this HincIl site after
TaqI digestion of pCAT, followed by Klenow repair of the
ends (Fig. SB). The resulting plasmid, pIE-1/CAT, was used
to transfect S. frugiperda cells. As shown in Fig. 5, CAT was
expressed in uninfected cells, as well as in infected cells,
indicating that the gene which trans-activated 39K gene
expression was an immediate-early gene by definition be-
cause prior viral protein synthesis was not required for
expression.
Construction of a plasmid containing 39CAT and IE-1. A
plasmid containing 38CAT and the gene required for its
expression was constructed. A ClaI subclone of pEcoRI-B,
cloned in the opposite orientation as pIE-1 relative to
multiple cloning site, was digested with PstI. PstI cut in the
multiple cloning site and at 97.0 m.u. The resulting 3-kb
fragment was cloned into the PstI site of 39CAT-4 (Fig. 6A).
The CAT activity induced by the 39CAT-IE-1 plasmid was
equivalent to the activity induced by cotransfection of the
two separate plasmids (Fig. 6B).
DISCUSSION
We examined the temporal regulation of an early gene of
the baculovirus AcNPV. A protein having a molecular
weight of 39,000 (39K) is the most abundantly expressed
early protein and is also synthesized late in infection. To
study the temporal regulation of this protein, we cloned the
bacterial CAT gene under the control of the 39K promoter
and assayed for the induction of the CAT gene to monitor the
expression of the 39K gene.
Because baculovirus genes apparently are not spliced (26),
we used Si nuclease to map the 5' ends of 39K transcripts
isolated at 6 and 18 h postinfection. With RNA isolated 6 h
postinfection, a major transcriptional start site was mapped
124 nucleotides upstream from the initiating AUG codon of
the 39K gene. Two minor start sites were detected 3 and 7
nucleotides upstream from the major site. With RNA iso-
lated 18 h postinfection, a major late transcriptional start site
was mapped 23 nucleotides upstream from the major early
site. The sequence of the 39K promoter indicates that the
early and late transcripts should code for the same protein,
because there are no initiating AUG codons located between
the two sites. Expression of the CAT gene under the control
of both promoters indicates that early and late transcripts
direct the synthesis of 39K. The use of dual promoters for
early and late genes has been described previously for genes
of vaccinia virus (10), and simian virus 40 (43), and for a
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,EcoRIl
Pstl
FIG. 6. Construction of a single clone containing 39CAT and the gene required for its expression (A) and 39CAT expression in transfected
cells (B). (A) A plasmid containing the ClaI fragment ofEcoRI fragment B (opposite orientation of the plasmid mentioned above) was digested
with PstI, which cut in the multiple cloning site and in the insertion. The resulting 3.0-kb fragment was cloned into the PstI site of 39CAT-4.
(B) Results of a CAT assay done with cells cotransfected with 39CAT-4 and pCIaI(EcoRI-B) (lane 1) or cells transfected with plasmid
39CAT-4/IE-1 alone (lane 2). CM, Input unacetylated chloramphenicol; Ac-Cm, acetylated chloramphenicol products.
developmentally regulated gene of Drosophila melanogaster
(4).
The 5' end of another minor early transcript was detected
approximately 400 bp upstream from the 39K gene. This
transcript is probably not involved in 39K gene expression,
because there are numerous AUG codons upstream from the
39K gene. Overlapping unspliced transcripts have been
described previously in several other regions of the AcNPV
genome (15, 27), as well as in vaccinia virus (3, 29) and
herpes simplex virus (1, 42). Friesen and Miller (15) de-
scribed a 3' AcNPV coterminal nest of overlapping tran-
scripts in which the smaller RNAs were synthesized early
and the larger RNAs were synthesized later. These authors
proposed a model in which upstream promoters are sequen-
tially activated, accompanied by deactivation ofdownstream
promoters.
We transfected S. frugiperda cells with seven plasmids
which had the CAT gene inserted at various positions in the
39K gene 5' nontranslated leader and coding sequences. To
confirm that the assignment of the initiating AUG codon was
correct, we tested in-phase and out-of-phase fusion proteins.
CAT activity was detected in AcNPV-infected cells but not
in uninfected cells, indicating that the 39K gene requires a
viral function and is therefore not an immediate-early gene.
Because expression of the 39K gene can be detected as early
as 3 to 6 h postinfection and after DNA synthesis (37), the
39K gene should be classified as a delayed-early/late gene.
The gene which trans-activates 39K gene expression was
functionally mapped by cotransfecting cells with 39CAT-4
and fragments of viral DNA, followed by an assay for CAT
activity. The gene required for 39K gene expression was
designated IE-1 (for immediate-early gene 1). IE-1 was
demonstrated to be an immediate-early gene by cloning the
CAT gene under the control of the IE-1 promoter. IE-1-CAT
was efficiently expressed in uninfected cells as well as in
infected cells. IE-1 did not stimulate pAC3906, the plasmid
in which the early promoter was deleted and the CAT gene
was apparently under the control of the late promoter. This
result indicates that IE-1 trans-activates the delayed early
half of the tandem promoter and that the late half is differ-
entially regulated. It will be of interest to determine whether
IE-1 trans-activates all delayed-early genes or whether other
viral factors are required.
Functional mapping with CAT was used previously to map
the trans-activating gene of human T-cell lymphtropic vi-
ruses (2, 38, 39). A similar procedure with the thymidine
kinase gene was used to map the structural protein which
activates herpes simplex virus ICP4 (8). Traditionally, regu-
latory genes have been identified by using temperature-
sensitive mutants. Cotransfection with CAT plasmids should
be useful for functional mapping of viral genomes when
libraries of temperature-sensitive mutants are not available.
The mutation of an early temperature-sensitive mutant of
AcNPV, blocked at an early stage of replication, was
mapped to 90.7 to 1.9 m.u. (33), the same region of the
genome as IE-1, indicating that the two procedures are
complimentary. We intend to use the cotransfection map-
ping procedure to identify the gene(s) required for expres-
sion of pAc3906.
The AcNPV IE-1 gene product has a trans-acting regula-
tory role in 39K gene expression. trans-Acting regulatory
genes have been described in adenoviruses (5, 23), simian
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virus 40 (7, 24), herpes simplex virus (11, 44), and human
T-cell lymphotrophic viruses (2, 38, 39). While these genes
are functionally similar, their mechanisms of action may
differ. Simian virus 40 T-antigen acts by direct binding to
specific DNA sequences (7, 24), and the nucleotide sequence
of the trans-acting gene of human T-cell lymphotrophic
viruses is consistent with a DNA-binding activity (39).
However, adenovirus type 5 and herpes simplex virus ap-
pear to act indirectly (19, 22) and may inactivate a host cell
factor which inhibits viral transcription (34). It will be
interesting to determine whether IE-1 acts at the level of
transcription, the nucleotide sequence of IE-1, and the
cellular location of the gene product.
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